Physician profile
Patrick T Maddox
NPI 1609971605
$2,183.25
in general payments reported to CMS, 2019-2025
11 companies · $89.82 in 2025
The $89.82 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $1,374 · 2021: $88.54 · 2022: $35.69 · 2023: $70.68 · 2024: $74.19 · 2025: $89.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,830.13 | 2019-2024 | Charlotte, Scopis Ent |
| Aerin Medical INC. | $59.84 | 2019-2024 | |
| Inspire Medical Systems, INC. | $56.94 | 2023 | Inspire |
| Intersect Ent, INC. | $56.53 | 2019-2022 | |
| Olympus America INC. | $31.56 | 2024-2025 | Rhino-Laryngo Videoscope |
| Integra Lifesciences Corporation | $28.24 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Harrow Eye, LLC | $26.78 | 2025 | Iheezo |
| Optinose US, INC. | $26.75 | 2020 | |
| Baxter Healthcare | $23.96 | 2024 | Perclot |
| Acclarent, INC | $23.39 | 2019 | |
| Glaxosmithkline, LLC. | $19.13 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Maddox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.